TABLE 1.
Average Daily MME | Daily MME, Median (IQR) | |||
---|---|---|---|---|
Definition | California | Florida | California | Florida |
All patients on opioid analgesics (mg) | ||||
Total days supply | 33 | 39 | 25 (18, 40) | 30 (20, 45) |
On-therapy days | 38 | 46 | 25 (18, 40) | 30 (20, 46) |
Fixed observation window | 17 | 23 | 3.3 (1.1, 13.9) | 4.2 (1.2, 19.8) |
Maximum daily dose | 52 | 65 | 30 (20, 50) | 33 (20, 60) |
No. patients | 2,430,870 | 1,485,591 | 2,430,870 | 1,485,591 |
Average on-therapy days (d) | 30 | 34 | 13 (5, 56) | 17 (3, 69) |
Immediate-release only (mg) | ||||
Total days supply | 30 | 34 | 24 (17, 38) | 30 (19, 40) |
On-therapy days | 31 | 35 | 25 (18, 38) | 30 (19, 43) |
Fixed observation window | 10 | 13 | 2.7 (1.1, 10.2) | 3.3 (1.1, 13.0) |
Maximum daily dose | 40 | 45 | 30 (20, 45) | 30 (20, 50) |
No. patients | 2,273,028 | 1,338,828 | 2,273,028 | 1,338,828 |
Average on-therapy days (d) | 27 | 30 | 10 (5, 46) | 12 (3, 58) |
Extended-release only (mg) | ||||
Total days supply | 90 | 87 | 60 (30, 120) | 60 (30, 120) |
On-therapy days | 104 | 97 | 62 (31, 121) | 63 (32, 120) |
Fixed observation window | 73 | 67 | 42 (15, 90) | 41 (14, 90) |
Maximum daily dose | 154 | 143 | 90 (45, 180) | 90 (55, 180) |
No. patients | 40,038 | 26,039 | 40,038 | 26,039 |
Average on-therapy days (d) | 61 | 60 | 75 (30, 89) | 73 (29, 89) |
Extended-release and immediate-release (mg) | ||||
Total days supply | 74 | 83 | 55 (38, 90) | 66 (44, 108) |
On-therapy days | 144 | 160 | 100 (63, 172) | 123 (75, 210) |
Fixed observation window | 123 | 133 | 82 (42, 151) | 98 (51, 181) |
Maximum daily dose | 251 | 268 | 173 (105, 300) | 200 (120, 345) |
No. patients | 117,804 | 120,724 | 117,804 | 120,724 |
Average on-therapy days (d) | 74 | 74 | 88 (63, 92) | 88 (67, 92) |
IQR indicates interquartile range; MME, milligrams of morphine equivalents.